Duncan Barbara Gayle
Halozyme Therapeutics, Inc. · Director
Duncan Barbara Gayle is listed in public filings as director. This Duncan Barbara Gayle insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Halozyme Therapeutics, Inc. (HALO), Ovid Therapeutics Inc. (OVID), and Atea Pharmaceuticals, Inc. (AVIR). Investors use Duncan Barbara Gayle's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $398k6k shares | Grant / ExerciseMay 5, 2026 | $397.9K6k shares | $65.87 | -- | |
| --23.7k shares | Grant / ExerciseMay 5, 2026 | Disclosure amount unavailable3.8k shares | -- | -- |